
Performance · Recovery · Longevity
Catalogue
Browse “Muscle/Performamnce, Recovery/Tissue, Weight Loss/Metabolic and Research Peptides“ and advanced wellness compounds. Prices are shown in South African Rand (ZAR).
Select a product to view available quantities, specifications and regulatory status. Quantities, documentation and pricing are confirmed before dispatch.
Tirzepatide 30mg (TIDLIRA 30 Filled Pen)
|
Category: |
Weight Loss / Metabolic / Longevity |
|
Price: |
R 2250.00 |
|
{{variant.name}}:
|
{{opt.name}}
{{opt.name}}
|
TEST RUN WELLNESS Tidlira 30 | Tirzepatide 30mg Multi-Dose Pen
Tidlira 30 (Tirzepatide 30mg) – Premium dual GLP-1 & GIP receptor agonist for advanced weight loss and glucose management. 30mg multi-dose pen with 8 needles included. Fast SA delivery.
Product Overview
Tidlira 30 is a Tirzepatide 30mg multi-dose pre-filled pen. It is a dual GLP-1 & GIP receptor agonist for advanced weight loss and glucose management.
How Tirzepatide Works: Dual GIP/GLP-1 Pathway Agonist
Tirzepatide is a first-in-class dual agonist that activates both the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors.
This dual action leads to improved insulin secretion, reduced glucagon release, slowed gastric emptying, and significantly enhanced satiety. The GIP component is believed to complement GLP-1 by improving fat metabolism and reducing nausea compared to GLP-1-only agonists.
Body Recomposition Benefits
Beyond weight loss, Tirzepatide promotes favourable body recomposition by preferentially reducing fat mass while preserving lean muscle mass when combined with adequate protein intake and resistance training. Clinical studies show significant reductions in visceral and subcutaneous fat, improved waist-to-hip ratio, and better metabolic markers.
Titration Protocol
Tirzepatide is typically initiated at a low dose and escalated slowly to minimise gastrointestinal side effects. A standard titration schedule (as used in clinical trials) is:
· Week 1–4: 2.5 mg once weekly
· Week 5–8: 5 mg once weekly
· Week 9–12: 7.5 mg once weekly
· Week 13–16: 10 mg once weekly
· Week 17+: 12.5 mg or 15 mg once weekly (maintenance, as tolerated)
Doses are administered subcutaneously once weekly, with or without food. Dose escalation should only occur if the current dose is well tolerated.
Combination Therapy
Tirzepatide may be used in combination with other agents under medical supervision. Common adjuncts include metformin for glycaemic control, or resistance training and high-protein diets to enhance body recomposition.
Combining GLP-1/GIP agonists with other weight-loss peptides (e.g., AOD-9604, MOTS-c) is sometimes explored in wellness protocols, but safety and efficacy data are limited. Always consult a healthcare professional before combining therapies.
Technical Specifications
Product Name: Tidlira 30
Peptide: Tirzepatide
Concentration: 30mg per pre-filled pen
Form: Multi-dose pen
What's In The Box: 1x 30mg Pen & 8x Needles
Supplier: Test Run Wellness (Wellness.testrun)
⚕️ Important Medical Notice
Please consult your medical practitioner regarding your body requirements, as the dosing information provided contains guideline dosages. Tidlira 30 is intended for use under professional medical supervision.
Regulatory notice. Test Run Wellness is an independent supplier and is not the manufacturer of the products referenced. No product should be used without appropriate regulatory authorisation and professional medical oversight.